Drug Research

Exploring Novel Excipients for Next Generation Drug Formulation The landscape of pharmaceutical development finds itself at a critical juncture where the complexity of drug molecules increasingly outpaces the capabilities of traditional formulation approaches. Novel excipients drug formulation represents not merely...

Advances in Lipid-Based Drug Formulation for Solubility Enhancement The pharmaceutical industry faces a persistent challenge that threatens to derail promising drug candidates before they reach patients. Poor aqueous solubility afflicts over 70% of new molecular entities in development pipelines, creating...

Revolutionizing Oral Drug Delivery with Nanotechnology The pharmaceutical landscape stands at a transformative juncture where nanotechnology oral drug delivery systems are reshaping how medications reach their therapeutic targets. This convergence of nanoscience and pharmaceutical formulation addresses fundamental challenges that have...

Biopharmaceutical Formulation Challenges and Stability Solutions The biopharmaceutical revolution has fundamentally transformed therapeutic medicine, with protein-based therapeutics including monoclonal antibodies, fusion proteins, antibody-drug conjugates, and advanced biologic systems becoming cornerstones of treatment for cancer, autoimmune diseases, metabolic disorders, and numerous...

Enhancing Bioavailability Through Advanced Drug Delivery Platforms The pharmaceutical industry confronts an enduring challenge where promising therapeutic molecules fail clinical translation due to inadequate bioavailability. Advanced drug delivery bioavailability enhancement has emerged as a critical enabler transforming compounds with poor...

The pharmaceutical industry confronts a formidable obstacle that threatens to derail promising therapeutic candidates before they reach patients. Poor aqueous solubility afflicts over 70% of new chemical entities in development pipelines, creating fundamental challenges for drug absorption and bioavailability...

SAE Media Group is proud to announce the release of the official brochure for AI in Drug Discovery 2026, taking place 9–10 March 2026 in London. The newly published agenda highlights how artificial intelligence is transforming pharmaceutical R&D, from...